DOI: 10.1007/s00259-017-3773-6Pages: 1937-1939

Response to the letter by Adams and Kwee, entitled: “Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma”

1. Bordeaux University Hospital, Department of Nuclear Medicine

2. Hôpital Haut-Lévêque

3. Bordeaux University Hospital, Department of Hematological Oncology

Correspondence to:
Elif Hindié
Email: elif.hindie@chu-bordeaux.fr

Close

Abstract

To access the full text, please Sign in

If you have institutional access, please click here

  • Online: Jul 13, 2017

Article Tools

eanm
EJNMMI Ad